This review summarizes the current research progress on the role of PDE4 and its subtypes in regulating cAMP signaling pathways and the inflammatory response in mediating symptoms of AD/ADRD and MDD, with a focus on investigating the crucial role of PDE4 in the pathogenesis of neuropsychiatric indications. Here, PDE4A is linked to Alzheimer disease.